The clinical pharmacogenetics implementation consortium (CPIC): facilitating the adoption of pharmacogenetics into routine clinical practice and the electronic health record.

被引:0
|
作者
Caudle, Kelly E. [1 ]
Hoffman, James M. [1 ]
Whirl-Carrillo, Michelle [2 ]
Haidar, Cyrine E. [1 ]
Crews, Kristine R. [1 ]
Klein, Teri E. [2 ]
Relling, Mary V. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[2] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
来源
PHARMACOTHERAPY | 2014年 / 34卷 / 10期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
286
引用
收藏
页码:E251 / E252
页数:2
相关论文
共 50 条
  • [21] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype
    Relling, M. V.
    McDonagh, E. M.
    Chang, T.
    Caudle, K. E.
    McLeod, H. L.
    Haidar, C. E.
    Klein, T.
    Luzzatto, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (02) : 169 - 174
  • [22] Development, Validation and Clinical Implementation of Reporting Pipeline for PGx Results from Targeted Genotyping Using Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Database
    Mroz, P.
    Allen, J.
    Bradley, S.
    Butler, T.
    Johnson, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S80 - S80
  • [23] PHARMACOGENETICS IN THE CLINICAL PRACTICE: DESIGN AND IMPLEMENTATION OF A CUSTOMIZED PHARMACOGENETICS GENOTYPING ARRAY (CLINPHARMARRAY®)
    Munoz, M.
    Dapia, I
    Tenorio, J.
    Arias, P.
    Zabala, R. H.
    Tong, H. Y.
    Frias, J.
    Lapunzina, P.
    Carcas, A. J.
    Borobia, A. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 53 - 53
  • [24] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron
    Bell, G. C.
    Caudle, K. E.
    Whirl-Carrillo, M.
    Gordon, R. J.
    Hikino, K.
    Prows, C. A.
    Gaedigk, A.
    Agundez, J. A. G.
    Sadhasivam, S.
    Klein, T. E.
    Schwab, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (02) : 213 - 218
  • [25] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy
    Desta, Zeruesenay
    Gammal, Roseann S.
    Gong, Li
    Whirl-Carrillo, Michelle
    Gaur, Aditya H.
    Sukasem, Chonlaphat
    Hockings, Jennifer
    Myers, Alan
    Swart, Marelize
    Tyndale, Rachel F.
    Masimirembwa, Collen
    Iwuchukwu, Otito F.
    Chirwa, Sanika
    Lennox, Jeffrey
    Gaedigk, Andrea
    Klein, Teri E.
    Haas, David W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (04) : 726 - 733
  • [26] Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs
    Theken, Katherine N.
    Lee, Craig R.
    Gong, Li
    Caudle, Kelly E.
    Formea, Christine M.
    Gaedigk, Andrea
    Klein, Teri E.
    Agundez, Jose A. G.
    Grosser, Tilo
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (02) : 191 - 200
  • [27] Implementation and obstacles of pharmacogenetics in clinical practice: An international survey
    Abou Diwan, Elizabeth
    Zeitoun, Ralph I.
    Abou Haidar, Lea
    Cascorbi, Ingolf
    Zgheib, Nathalie Khoueiry
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (09) : 2076 - 2088
  • [28] Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice
    Matic, Maja
    de Wildt, Saskia N.
    Tibboel, Dick
    van Schaik, Ron H. N.
    CLINICAL CHEMISTRY, 2017, 63 (07) : 1204 - 1213
  • [29] COST EFFECTIVENESS (CE) OF PHARMACOGENETIC (PGX) TESTING FOR DRUGS WITH CLINICAL PHARMACOGENETICS IMPLEMENTATION CONSORTIUM (CPIC) GUIDELINES: A SYSTEMATIC REVIEW.
    Patel, J.
    Morris, S.
    Alsaidi, A.
    Cruz, A.
    Verbyla, A.
    Macfarlane, C.
    Bauer, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S69 - S69
  • [30] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2C9andHLA-BGenotypes and Phenytoin Dosing: 2020 Update
    Karnes, Jason H.
    Rettie, Allan E.
    Somogyi, Andrew A.
    Huddart, Rachel
    Fohner, Alison E.
    Formea, Christine M.
    Ta Michael Lee, Ming
    Llerena, Adrian
    Whirl-Carrillo, Michelle
    Klein, Teri E.
    Phillips, Elizabeth J.
    Mintzer, Scott
    Gaedigk, Andrea
    Caudle, Kelly E.
    Callaghan, John T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (02) : 302 - 309